NY A09697 | 2021-2022 | General Assembly

Status

Spectrum: Strong Partisan Bill (Democrat 11-1)
Status: Introduced on March 28 2022 - 25% progression, died in chamber
Action: 2022-06-03 - substituted by s8633a
Text: Latest bill text (Amended) [HTML]

Summary

Establishes the nightlife opioid antagonist program to allow certain establishments to apply and receive an opioid antagonist, free of charge, to be administered to patrons, staff or individuals on premises of such establishment in the case of an emergency.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Establishes the nightlife opioid antagonist program to allow certain establishments to apply and receive an opioid antagonist, free of charge, to be administered to patrons, staff or individuals on premises of such establishment in the case of an emergency.

Sponsors


Roll Calls

2022-06-03 - Assembly - Assembly Rules Committee: Favorable (Y: 28 N: 0 NV: 0 Abs: 3) [PASS]
2022-06-02 - Assembly - Assembly Ways And Means Committee: Favorable refer to committee Rules (Y: 33 N: 0 NV: 0 Abs: 2) [PASS]

History

DateChamberAction
2022-06-03Assemblysubstituted by s8633a
2022-06-03Assemblyrules report cal.709
2022-06-03Assemblyreported
2022-06-02Assemblyreported referred to rules
2022-06-02Assemblyreference changed to ways and means
2022-05-11Assemblyprint number 9697a
2022-05-11Assemblyamend and recommit to health
2022-03-28Assemblyreferred to health

Same As/Similar To

S08633 (Same As) 2022-12-23 - APPROVAL MEMO.72

New York State Sources


Bill Comments

feedback